BG106246A - Метод за предотвратяване растежа на тумори - Google Patents

Метод за предотвратяване растежа на тумори

Info

Publication number
BG106246A
BG106246A BG106246A BG10624601A BG106246A BG 106246 A BG106246 A BG 106246A BG 106246 A BG106246 A BG 106246A BG 10624601 A BG10624601 A BG 10624601A BG 106246 A BG106246 A BG 106246A
Authority
BG
Bulgaria
Prior art keywords
tumor growth
preventing tumor
growth
ltbr
lymphotoxin
Prior art date
Application number
BG106246A
Other languages
Bulgarian (bg)
English (en)
Inventor
Daniela MAENNEL
Thomas Hehlgans
Carola Seitz
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1999129488 external-priority patent/DE19929488A1/de
Priority claimed from DE2000104447 external-priority patent/DE10004447A1/de
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of BG106246A publication Critical patent/BG106246A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C07K14/5255—Lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Peptides Or Proteins (AREA)
BG106246A 1999-06-28 2001-12-19 Метод за предотвратяване растежа на тумори BG106246A (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1999129488 DE19929488A1 (de) 1999-06-28 1999-06-28 Verfahren zur Verhinderung von Tumorwachstum
DE2000104447 DE10004447A1 (de) 2000-02-03 2000-02-03 Verfahren zur Verhinderung von Tumorwachstum
PCT/EP2000/005738 WO2001000228A1 (de) 1999-06-28 2000-06-21 Verfahren zur verhinderung von tumorwachstum

Publications (1)

Publication Number Publication Date
BG106246A true BG106246A (bg) 2002-10-31

Family

ID=26004148

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106246A BG106246A (bg) 1999-06-28 2001-12-19 Метод за предотвратяване растежа на тумори

Country Status (20)

Country Link
EP (1) EP1189626B1 (pt)
JP (1) JP3822822B2 (pt)
KR (1) KR20020016852A (pt)
CN (1) CN1359297A (pt)
AT (1) ATE410180T1 (pt)
AU (1) AU5406000A (pt)
BG (1) BG106246A (pt)
BR (1) BR0012006A (pt)
CA (1) CA2376920A1 (pt)
DE (1) DE50015391D1 (pt)
ES (1) ES2313893T3 (pt)
HK (1) HK1047045A1 (pt)
HU (1) HUP0201804A2 (pt)
IL (1) IL147180A0 (pt)
MX (1) MXPA01013367A (pt)
NO (1) NO20016380L (pt)
PL (1) PL353057A1 (pt)
SK (1) SK18852001A3 (pt)
TR (1) TR200103841T2 (pt)
WO (1) WO2001000228A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL134994A0 (en) 2000-03-09 2001-05-20 Yeda Res & Dev Coupled two way clustering analysis of data
CN1761680A (zh) 2002-12-26 2006-04-19 武田药品工业株式会社 肿瘤迁移抑制素衍生物及其用途
CA2571420A1 (en) 2004-06-25 2006-01-05 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
JP2009510172A (ja) * 2005-10-04 2009-03-12 ジョンズ ホプキンス ユニバーシティ 炎症を処置するための組成物および方法
AR058584A1 (es) 2005-12-22 2008-02-13 Takeda Pharmaceutical Derivados de metastina y uso de los mismos
US8404643B2 (en) 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
JO3048B1 (ar) 2006-10-25 2016-09-05 Takeda Pharmaceuticals Co مشتقات متاستين واستخدامها
US8440185B2 (en) 2006-12-26 2013-05-14 The Johns Hopkins University Compositions and methods for the treatment of immunologic disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925351A (en) * 1995-07-21 1999-07-20 Biogen, Inc. Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
KR100584704B1 (ko) * 1996-10-25 2006-05-30 바이오겐 아이덱 엠에이 인코포레이티드 면역 질환을 치료하기 위한 치료제로서의 가용성 림포톡신-베타 수용체, 항림포톡신 수용체 항체 및 항림포톡신 리간드 항체
CA2319698A1 (en) * 1998-01-30 1999-08-05 Biogen, Inc. Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway

Also Published As

Publication number Publication date
PL353057A1 (en) 2003-10-06
DE50015391D1 (de) 2008-11-20
MXPA01013367A (es) 2002-07-02
EP1189626A1 (de) 2002-03-27
JP2003503359A (ja) 2003-01-28
WO2001000228A1 (de) 2001-01-04
HK1047045A1 (zh) 2003-02-07
IL147180A0 (en) 2002-08-14
EP1189626B1 (de) 2008-10-08
NO20016380D0 (no) 2001-12-27
ES2313893T3 (es) 2009-03-16
ATE410180T1 (de) 2008-10-15
KR20020016852A (ko) 2002-03-06
CN1359297A (zh) 2002-07-17
JP3822822B2 (ja) 2006-09-20
HUP0201804A2 (en) 2002-09-28
CA2376920A1 (en) 2001-01-04
BR0012006A (pt) 2002-03-12
AU5406000A (en) 2001-01-31
SK18852001A3 (sk) 2002-12-03
TR200103841T2 (tr) 2002-06-21
NO20016380L (no) 2001-12-27

Similar Documents

Publication Publication Date Title
DK0988301T3 (da) Imidazolylcykliske acetaler
AU7743001A (en) Cyclopentanoindoles, compositions containing such compounds and methods of treatment
BG63692B1 (bg) Производни на заместен 2-циклопентил-4-/4-флуорофенил/-7,7-диметил-тетрахидрохинолин и метод за получаването им
MY169308A (en) Treatment of tnf? related disorders
GEP20074267B (en) Receptor nucleic acids and polypeptides
BG102241A (bg) Инхибитори на клетъчна адхезия
IL139956A0 (en) Conformationally constrained backbone cyclized somatostatin analogs
JO2481B1 (en) Silo cano-indol compounds have fluoride substitution and formulations containing such compounds and their treatment methods
EA200100971A1 (ru) Новые соединения и композиции в качестве ингибиторов протеазы
DZ3265A1 (fr) Derives de 4,5-diaryl-3(2h)-furanone comme inhibiteurs de cyclo-oxygenase-2
UA66865C2 (uk) Інденопіролокарбазоли, фармацевтична композиція, спосіб інгібування кіназної активності та спосіб лікування (варіанти)
ATE364695T1 (de) Gekürzte lösliche typ-i-rezeptoren für tumor- nekrose-faktor
EA200500244A1 (ru) Тетрапропиламмония тетратиомолибдат и родственные соединения для антиангиогенной терапии
EA200001129A2 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
EA200601217A1 (ru) Новые конденсированные пирролокарбазолы
BG106246A (bg) Метод за предотвратяване растежа на тумори
EP1435941B8 (en) Wortmannin analogs and methods of using same
DE60015508T2 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
NZ514696A (en) IL-8 receptor antagonists
PT1051187E (pt) Tratamento de linfomas foliculares usando inibidores da via da linfotoxina (lt)
ATE372330T1 (de) N-sulfonylurea-apoptosis-förderer
AU7525398A (en) Inhibitors for urokinase receptor
WO2005037221A3 (en) Cystatin c as an antagonist of tgf-b and methods related thereto
MXPA03005400A (es) Metodo para preparacion de 11 (12)-pentadecen-15-olidos.
BG102318A (en) Epoxy-azetidinons, their preparation and application